Company logo

SAVA - Cassava Sciences, Inc.

NASDAQ -> Healthcare -> Biotechnology
Austin, United States
Type: Equity

SAVA price evolution
SAVA
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $121.14 $142.35 $168.44 $187.47
Short term investments
Net receivables $0.96 $1.28 $1.33
Inventory
Total current assets $129.63 $150.18 $174.53 $195
Long term investments
Property, plant & equipment $21.85 $22.08 $22.33 $22.61
Goodwill & intangible assets $0.18 $0.27 $0.39 $0.5
Total noncurrent assets $22.03 $22.34 $22.71 $23.11
Total investments
Total assets $151.66 $172.53 $197.25 $218.11
Current liabilities
Accounts payable $10.57 $9.49 $10.34 $8.24
Deferred revenue
Short long term debt
Total current liabilities $14.2 $17.41 $17.89 $13.91
Long term debt
Total noncurrent liabilities $0.2
Total debt
Total liabilities $14.2 $17.41 $17.89 $14.11
Shareholders' equity
Retained earnings -$380.77 -$359.85 -$334.2 -$307.82
Other shareholder equity
Total shareholder equity $137.47 $155.12 $179.35 $204
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $121.14 $201.01 $233.44 $93.51
Short term investments
Net receivables $0.96
Inventory
Total current assets $129.63 $211.23 $244.48 $93.99
Long term investments
Property, plant & equipment $21.85 $22.99 $20.83 $0.31
Goodwill & intangible assets $0.18 $0.62 $1.07
Total noncurrent assets $22.03 $23.61 $22.3 $0.31
Total investments
Total assets $151.66 $234.83 $266.78 $94.3
Current liabilities
Accounts payable $10.57 $4.02 $7.13 $0.91
Deferred revenue
Short long term debt $0.1 $0.1 $0.06
Total current liabilities $14.2 $7.06 $12.53 $1.86
Long term debt $0.04 $0.14 $0.23
Total noncurrent liabilities $0.23 $0.33 $0.23
Total debt $0.14 $0.24 $0.29
Total liabilities $14.2 $7.29 $12.87 $2.1
Shareholders' equity
Retained earnings -$380.77 -$283.55 -$207.31 -$174.92
Other shareholder equity
Total shareholder equity $137.47 $227.54 $253.91 $92.2
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $18.73 $23.6 $24.97 $22.12
Selling, general & administrative $4.06 $4.28 $3.81 $4.39
Total operating expenses $22.79 $27.88 $28.78 $26.51
Operating income -$22.79 -$27.88 -$28.78 -$26.51
Income from continuing operations
EBIT -$20.92 -$25.65 -$26.38 -$24.27
Income tax expense
Interest expense
Net income
Net income -$20.92 -$25.65 -$26.38 -$24.27
Income (for common shares) -$20.92 -$25.65 -$26.38 -$24.27
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $89.42 $68.03 $24.81 $3.05
Selling, general & administrative $16.53 $11.99 $8.05 $3.74
Total operating expenses $105.96 $80.02 $32.87 $6.45
Operating income -$105.96 -$80.02 -$32.87 -$6.45
Income from continuing operations
EBIT -$97.22 -$76.25 -$32.38 -$6.33
Income tax expense
Interest expense
Net income
Net income -$97.22 -$76.25 -$32.38 -$6.33
Income (for common shares) -$97.22 -$76.25 -$32.38 -$6.33
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$20.92 -$25.65 -$26.38 -$24.27
Operating activities
Depreciation $0.36 $0.39 $0.39 $0.39
Business acquisitions & disposals
Stock-based compensation $2.13 $0.95 $0.83 $0.67
Total cash flows from operations -$22.32 -$26.53 -$19.92 -$13.26
Investing activities
Capital expenditures -$0.04 -$0.02 $0.01 -$0.36
Investments
Total cash flows from investing -$0.04 -$0.02 $0.01 -$0.36
Financing activities
Dividends paid
Sale and purchase of stock $1.14 $0.46 $0.89 $0.06
Net borrowings
Total cash flows from financing $1.14 $0.46 $0.89 $0.06
Effect of exchange rate
Change in cash and equivalents -$21.21 -$26.09 -$19.03 -$13.55
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$97.22 -$76.25 -$32.38 -$6.33
Operating activities
Depreciation $1.53 $1.3 $0.53 $0.02
Business acquisitions & disposals
Stock-based compensation $4.59 $2.07 $1.76 $0.99
Total cash flows from operations -$82.03 -$77.51 -$30.2 -$5.38
Investing activities
Capital expenditures -$0.41 -$2.71 -$22.21 $0.36
Investments
Total cash flows from investing -$0.41 -$2.71 -$22.21 $0.36
Financing activities
Dividends paid
Sale and purchase of stock $2.56 $47.8 $192.34 $75.45
Net borrowings
Total cash flows from financing $2.56 $47.8 $192.34 $75.45
Effect of exchange rate
Change in cash and equivalents -$79.88 -$32.42 $139.93 $70.42
Fundamentals
Market cap $862.48M
Enterprise value $741.34M
Shares outstanding 42.24M
Revenue $0.00
EBITDA -$95.69M
EBIT -$97.22M
Net Income -$97.22M
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio -8.87
EV/Sales N/A
EV/EBITDA -7.75
EV/EBIT -7.63
P/S ratio N/A
P/B ratio 6.27
Book/Share 3.25
Cash/Share 2.87
EPS -$2.30
ROA -52.58%
ROE -57.53%
Debt/Equity 0.10
Net debt/EBITDA 1.12
Current ratio 9.13
Quick ratio 9.13